Intermediate effects of mindfulness practice on the brain activity of college students: An EEG study.

Mindfulness is an intervention that was used in many psychiatry treatments. In this study, the subject experienced two different states: (1) attention (i.e., listening to a podcast) and (2) mindfulness (i.e., meditation). Twenty-two students were included in a Mindfulness-Based Stress Reduction (MBSR) course with EEG recording sessions on week four and week six. Brain dynamics were investigated to elucidate the complexity and connectivity of the brain. The alpha PSD increased in all brain areas during mindfulness in both weeks. For complexity, Fractal Dimension (FD) increased significantly during meditation in the week six recording. When comparing the FD in the mindfulness state of week four and week six, we also witnessed a significant increase in the following week. The coherence of the interhemispheric frontal and temporal regions increased significantly in both weeks. In conclusion, the subject successfully transferred from attention to mindfulness, demonstrated by the alpha changes when going from podcast to meditating. An enhancement in brain complexity was found, suggesting an augmentation in cognitive function. Finally, the coherence exhibits strengthened connections in the frontal area.

Local delivery of rapamycin: a toxicity and efficacy study in an experimental malignant glioma model in rats.

Rapamycin, an anti-proliferative agent, is effective in the treatment of renal cell carcinoma and recurrent breast cancers. We proposed that this potent mammalian target of rapamycin inhibitor may be useful for the treatment of gliomas as well. We examined the cytotoxicity of rapamycin against a rodent glioma cell line, determined the toxicity of rapamycin when delivered intracranially, and investigated the efficacy of local delivery of rapamycin for the treatment of experimental malignant glioma in vivo. We also examined the dose-dependent efficacy of rapamycin and the effect when locally delivered rapamycin was combined with radiation therapy. Rapamycin was cytotoxic to 9L cells, causing 34% growth inhibition at a concentration of 0.01 µg/mL. No in vivo toxicity was observed when rapamycin was incorporated into biodegradable caprolactone-glycolide (35:65) polymer beads at 0.3%, 3%, and 30% loading doses and implanted intracranially. Three separate efficacy studies were performed to test the reproducibility of the effect of the rapamycin beads as well as the validity of this treatment approach. Animals treated with the highest dose of rapamycin beads tested (30%) consistently demonstrated significantly longer survival durations than the control and placebo groups. All dose-escalating rapamycin bead treatment groups (0.3%, 3% and 30%), treated both concurrently with tumor and in a delayed manner after tumor placement, experienced a significant increase in survival, compared with controls. Radiation therapy in addition to the simultaneous treatment with 30% rapamycin beads led to significantly longer survival duration than either therapy alone. These results suggest that the local delivery of rapamycin for the treatment of gliomas should be further investigated.